Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | DGKA | P23743 | 2/20 | 0.46 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.45 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.45 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.45 |
| ▸ | PRKCA | P17252 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30180550 | 1.00 | MGLL (0.51) | MGLLEPHX2DGKAPRKCEPRKCQ | |
| SCHEMBL28968652 | 1.00 | MGLL (0.51) | MGLLEPHX2DGKAPRKCEPRKCQ | |
| SCHEMBL441411 | 1.00 | MGLL (0.51) | MGLLEPHX2DGKAPRKCEPRKCQ | |
| Water SCHEMBL6549699 | 0.99 | MGLL (0.50) | MGLLEPHX2DGKAPRKCEPRKCQ | |
| Hydrochloric Acid SCHEMBL421821 | 0.99 | MGLL (0.50) | MGLLEPHX2DGKAPRKCEPRKCQ | |
| Hydrochloric Acid SCHEMBL1047267 | 0.99 | MGLL (0.50) | MGLLEPHX2DGKAPRKCEPRKCQ | |
| Hydrochloric Acid SCHEMBL29396916 | 0.99 | MGLL (0.50) | MGLLEPHX2DGKAPRKCEPRKCQ | |
| Hydrochloric Acid SCHEMBL28736736 | 0.98 | MGLL (0.49) | MGLLEPHX2DGKAPRKCEPRKCQ | |
| SCHEMBL1044584 | 0.93 | DGKA (0.50) | MGLLEPHX2DGKAPRKCEPRKCQ | |
| Hydrochloric Acid SCHEMBL18209372 | 0.92 | DGKA (0.49) | MGLLEPHX2DGKAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0730404-B1 | AMPHIPHILIC IMIDAZOLINIUM DERIVATIVES | VALENTIS INC (US) | 2004-02-04 | — | — | EP | claimed |
| US-12616678-B2 | Methods to of aldehyde dehydrogenases for treatment of cancer | THE PENN STATE RESEARCH FOUNDATION (PA) | 2026-05-05 | — | — | US | disclosed |
| US-12551434-B2 | Zwitterionic polymer particle compositions and related methods | WAYNE STATE UNIVERSITY (US) | 2026-02-17 | — | — | US | disclosed |
| US-20250387367-A1 | METHODS AND COMPOSITIONS RELATING TO INHIBITION OF ALDEHYDE DEHYDROGENASES FOR TREATMENT OF CANCER | PENN STATE RES FOUND (US) | 2025-12-25 | — | — | US | disclosed |
| US-12036265-B2 | Compositions and methods relating to bone repair and regeneration | WAYNE STATE UNIVERSITY (US) | 2024-07-16 | — | — | US | disclosed |
| WO-2023235392-A1 | ELECTROPHORESIS-MEDIATED CHARACTERIZATION OF DNA CONTENT OF ADENO-ASSOCIATED VIRUS CAPSIDS | PERKINELMER HEALTH SCIENCES, INC. (US) | 2023-12-07 | — | — | WO | disclosed |
| US-20230392188-A1 | ELECTROPHORESIS-MEDIATED CHARACTERIZATION OF DNA CONTENT OF ADENO-ASSOCIATED VIRUS CAPSIDS | REVVITY HEALTH SCIENCES, INC. | 2023-12-07 | — | — | US | disclosed |
| US-20230301965-A1 | METHODS AND COMPOSITIONS RELATING TO INHIBITION OF ALDEHYDE DEHYDROGENASES FOR TREATMENT OF CANCER | THE PENN STATE RESEARCH FOUNDATION | 2023-09-28 | — | — | US | disclosed |
| US-20230225969-A1 | ZWITTERIONIC POLYMER PARTICLE COMPOSITIONS AND RELATED METHODS | WAYNE STATE UNIVERSITY | 2023-07-20 | — | — | US | disclosed |
| CN-116348126-A | Antiviral compositions and methods | 韦恩州立大学 | 2023-06-27 | — | — | CN | disclosed |
| EP-2430001-A1 | METHODS FOR THE PREPARATION OF AMPHIPHILIC NITROGEN CONTAINING IMIDAZOLINIUM DERIVATIVE COMPOUNDS | Juvaris Biotherapeutics, Inc. (US) | 2012-03-21 | — | — | EP | disclosed |
| US-8044215-B2 | Methods for the preparation of amphillic nitrogen containing imidazolinium derivative compounds | JUVARIS BIOTHERAPEUTICS, INC. (US) | 2011-10-25 | — | — | US | disclosed |
| US-20110229972-A1 | COMPOSITIONS AND METHODS FOR MATERIAL TRANSFER INTO CELLS | THE PENN STATE RESEARCH FOUNDATION (US) | 2011-09-22 | — | — | US | disclosed |
| WO-2011116383-A2 | COMPOSITIONS AND METHODS FOR MATERIAL TRANSFER INTO CELLS | THE PENN STATE RESEARCH FOUNDATION (US) | 2011-09-22 | — | — | WO | disclosed |
| WO-2010126978-A1 | METHODS FOR THE PREPARATION OF AMPHIPHILIC NITROGEN CONTAINING IMIDAZOLINIUM DERIVATIVE COMPOUNDS | JUVARIS BIOTHERAPEUTICS, INC. (US) | 2010-11-04 | — | — | WO | disclosed |
| US-20100280258-A1 | METHODS FOR THE PREPARATION OF AMPHILLIC NITROGEN CONTAINING IMIDAZOLINIUM DERIVATIVE COMPOUNDS | JUVARIS BIOTHERAPEUTICS, INC. (US) | 2010-11-04 | — | — | US | disclosed |
| EP-0730404-B1 | AMPHIPHILIC IMIDAZOLINIUM DERIVATIVES | VALENTIS INC (US) | 2004-02-04 | — | — | EP | disclosed |
| EP-0730404-A4 | AMPHIPHILIC IMIDAZOLINIUM DERIVATIVES | MEGABIOS CORP (US) | 1997-02-19 | — | — | EP | disclosed |
| EP-0730404-A1 | AMPHIPHILIC IMIDAZOLINIUM DERIVATIVES | MEGABIOS CORPORATION (US) | 1996-09-11 | — | — | EP | disclosed |
| WO-1995014380-A1 | AMPHIPHILIC IMIDAZOLINIUM DERIVATIVES | MEGABIOS CORPORATION (US) | 1995-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230225969-A1 | ZWITTERIONIC POLYMER PARTICLE COMPOSITIONS AND RELATED METHODS | IAPP, IGFBP6, SI | MGLL 886/4885EPHX2 3460/4885DGKA 1504/4885 |
| US-20100280258-A1 | METHODS FOR THE PREPARATION OF AMPHILLIC NITROGEN CONTAINING IMIDAZOLINIUM DERIVATIVE COMPOUNDS | NDC1, NUP205, NUP188 | MGLL 533/4885EPHX2 4612/4885DGKA 503/4885 |
| US-20250387367-A1 | METHODS AND COMPOSITIONS RELATING TO INHIBITION OF ALDEHYDE DEHYDROGENASES FOR TREATMENT OF CANCER | ALDH3A1, ALDH2, ADH1C | MGLL 316/4885EPHX2 263/4885DGKA 1266/4885 |
| US-12616678-B2 | Methods to of aldehyde dehydrogenases for treatment of cancer | ALDH1A1, ALDH3A1, ADH1C | MGLL 175/4885EPHX2 133/4885DGKA 1423/4885 |
| US-12551434-B2 | Zwitterionic polymer particle compositions and related methods | IAPP, GIPR, INSR | MGLL 81/4885EPHX2 3504/4885DGKA 1498/4885 |
| US-20230301965-A1 | METHODS AND COMPOSITIONS RELATING TO INHIBITION OF ALDEHYDE DEHYDROGENASES FOR TREATMENT OF CANCER | DPYD, ALDH2, DLD | MGLL 1204/4885EPHX2 517/4885DGKA 1097/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.